arrow
Return

Neurotransmission-related gene expression in the frontal pole is altered in subjects with bipolar disorder and schizophrenia

delete2023-04-08
delete2
delete
OA
AI
A
Adriana Medina
M
Megan Hastings Hagenauer *
D
David M. Krolewski
E
Evan Hughes
L
Liam Cannon Thew Forrester
D
David Walsh
M
Maria Waselus
E
Evelyn Richardson
C
Cortney A. Turner
A
Adolfo Sequeira
P
Preston Cartagena
R
Robert C. Thompson
M
Marquis P. Vawter
B
Blynn G. Bunney
R
R Myers
J
Jack D. Barchas
F
Francis S. Lee
A
Alan F. Schatzberg
W
William E. Bunney
H
Huda Akil
S
Stanley J. Watson
DOI:10.1038/s41398-023-02418-1delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
The frontal pole (Brodmann area 10, BA10) is the largest cytoarchitectonic region of the human cortex, performing complex integrative functions. BA10 undergoes intensive adolescent grey matter pruning prior to the age of onset for bipolar disorder (BP) and schizophrenia (SCHIZ), and its dysfunction is likely to underly aspects of their shared symptomology. In this study, we investigated the role of BA10 neurotransmission-related gene expression in BP and SCHIZ. We performed qPCR to measure the expression of 115 neurotransmission-related targets in control, BP, and SCHIZ postmortem samples (n = 72). We chose this method for its high sensitivity to detect low-level expression. We then strengthened our findings by performing a meta-analysis of publicly released BA10 microarray data (n = 101) and identified sources of convergence with our qPCR results. To improve interpretation, we leveraged the unusually large database of clinical metadata accompanying our samples to explore the relationship between BA10 gene expression, therapeutics, substances of abuse, and symptom profiles, and validated these findings with publicly available datasets. Using these convergent sources of evidence, we identified 20 neurotransmission-related genes that were differentially expressed in BP and SCHIZ in BA10. These results included a large diagnosis-related decrease in two important therapeutic targets with low levels of expression, HTR2B and DRD4, as well as other findings related to dopaminergic, GABAergic and astrocytic function. We also observed that therapeutics may produce a differential expression that opposes diagnosis effects. In contrast, substances of abuse showed similar effects on BA10 gene expression as BP and SCHIZ, potentially amplifying diagnosis-related dysregulation.
Keywords:
DORSOLATERAL PREFRONTAL CORTEX
RECEPTOR MESSENGER-RNA
CATECHOL-O-METHYLTRANSFERASE
ASTROCYTE ACTIVATION
5-HT2B RECEPTORS
MICE LACKING
DOPAMINE
GABA
METAANALYSIS
NEURONS
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Translational Psychiatry cover
Translational Psychiatry
IF:
6.2
Papers:
5.5K
Citations:
2.4W

Organization

H
HudsonAlpha Institute for Biotechnology
Scholars:
721
Papers: 432
Citations: 2.3K
University of California System cover
University of California System
Scholars:
37.2W
Papers: 33.6W
Citations: 6.6K
U
University of Michigan
Scholars:
6.4W
Papers: 5.3W
Citations: 124
U
university of michigan system
Scholars:
9.0W
Papers: 8.6W
Citations: 133
U
university of california irvine
Scholars:
2.2W
Papers: 1.7W
Citations: 55
researcher View more organizations